Bhat, Mamatha http://orcid.org/0000-0003-1960-8449
Clotet-Freixas, Sergi
Baciu, Cristina
Pasini, Elisa
Hammad, Ahmed
Ivanics, Tommy
Reid, Shelby
Azhie, Amirhossein
Angeli, Marc
Ghanekar, Anand
Fischer, Sandra
Sapisochin, Gonzalo
Konvalinka, Ana
Funding for this research was provided by:
Canadian Liver Foundation
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada
American Society of Transplantation
Canadian Donation and Transplant Research Program
Toronto General and Western Hospital Foundation (TGTWF 1617-464, TGTWF MKFTR 1718-1268)
Kidney Foundation of Canada Predictive Biomarker (KFOC160010)
Canadian Institutes of Health Research (CIHR148204)
Canada Foundation for Innovation (37205)
Kidney Research Scientist Core Education and National Training (KRES160004, KRES160005, KPPDF637713)
Article History
Received: 8 June 2021
Accepted: 3 November 2021
First Online: 18 November 2021
Declarations
:
: Patients who underwent LT for hepatitis B-induced HCC beyond Milan criteria between 2004 and 2015 were included in our study. This protocol was approved by the University Health Network (UHN) Institutional Review Board (REB#15-9989).
: Not applicable.
: The authors declare that they have no competing interests.